Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Schaeffer

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
CNS Drugs|June 24, 2017
Dopaminergic Therapies for Non-motor Symptoms in Parkinson's DiseaseEva Schaeffer, Daniela Berg
Neurological Research and Practice|June 3, 2026
The brain health bundle: integrating evidence-based strategies to guide neurological preventionEva Schaeffer, Daniela Berg
Brain and Behavior|March 30, 2021
Complications following REM sleep behavior disorderEva Schaeffer, Daniela Berg
Klinische Monatsblatter Fur Augenheilkunde|February 19, 2026
[Physical inactivity as a risk factor for neurodegeneration and sports medicine-based recommendations]Eva Schaeffer, Burkhard Weisser
The Lancet. Neurology|March 21, 2026
Lifestyle interventions for Parkinson's diseaseElke Kalbe, Eva Schaeffer
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2024
Response to Viewpoint by Bernhardt et alAnnika Kluge, Eva Schaeffer, Daniela Berg
Frontiers in Neurology|January 10, 2017
"Cueing" for Levodopa-Induced Dyskinesias in Parkinson's DiseaseEva Schaeffer, Gerd Linke, Daniela Berg
CNS Drugs|October 25, 2014
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's diseaseEva Schaeffer, Andrea Pilotto, Daniela Berg
Progress in Brain Research|April 6, 2020
Prodromal PD: A new nosological entityEva Schaeffer, Ronald B Postuma, Daniela Berg
Neurological Research and Practice|November 18, 2025
Environmental toxins in neurodegeneration - a narrative reviewKristína Kulcsárová, Johannes Heinrich Alexander Piel, Eva Schaeffer
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
CNS Drugs|June 24, 2017
Dopaminergic Therapies for Non-motor Symptoms in Parkinson's DiseaseEva Schaeffer, Daniela Berg
Neurological Research and Practice|June 3, 2026
The brain health bundle: integrating evidence-based strategies to guide neurological preventionEva Schaeffer, Daniela Berg
Brain and Behavior|March 30, 2021
Complications following REM sleep behavior disorderEva Schaeffer, Daniela Berg
Klinische Monatsblatter Fur Augenheilkunde|February 19, 2026
[Physical inactivity as a risk factor for neurodegeneration and sports medicine-based recommendations]Eva Schaeffer, Burkhard Weisser
The Lancet. Neurology|March 21, 2026
Lifestyle interventions for Parkinson's diseaseElke Kalbe, Eva Schaeffer
Movement Disorders : Official Journal of the Movement Disorder Society|July 24, 2024
Response to Viewpoint by Bernhardt et alAnnika Kluge, Eva Schaeffer, Daniela Berg
Frontiers in Neurology|January 10, 2017
"Cueing" for Levodopa-Induced Dyskinesias in Parkinson's DiseaseEva Schaeffer, Gerd Linke, Daniela Berg
CNS Drugs|October 25, 2014
Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's diseaseEva Schaeffer, Andrea Pilotto, Daniela Berg
Progress in Brain Research|April 6, 2020
Prodromal PD: A new nosological entityEva Schaeffer, Ronald B Postuma, Daniela Berg
Neurological Research and Practice|November 18, 2025
Environmental toxins in neurodegeneration - a narrative reviewKristína Kulcsárová, Johannes Heinrich Alexander Piel, Eva Schaeffer
Pageof 6